In ankylosing spondylitis, NAT10 mRNA together with neutrophil percentages could be employed to construct a novel predictive model to distinguish new-onset ankylosing spondylitis patients from RA and SLE [81]. Here, NAT10 is linked to rheumatoid arthritis.